Efficacy of Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Patients Undergoing Dose Reduction and Those With a Low Body Surface Area

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2014.281

Related search